Author | Davy James


Stem Cell Transplant May Reduce Disability in Patients with Multiple Sclerosis

April 09, 2015

Patients with relapsing-remitting multiple sclerosis (RRMS) who received a non-myeloablative hematopoietic stem cell transplant (HSCT) experienced improved measures of disability and quality of life.

Are Expensive New Hepatitis C Drugs Worth the High Cost?

July 01, 2014

Stephen Vogt, PharmD, Chief Executive Officer and President of BioPlus Specialty Pharmacy, discusses the ongoing debate surrounding the high price of Hepatitis C treatments versus the efficacy of the drug.

Study Finds Long-term Safety and Efficacy in Psoriatic Arthritis Treatment

June 30, 2014

Biologic agent golimumab effective over 5-year span in treating disease symptoms and improving quality of life.

Higher Inflammation Burden in Psoriatic Arthritis Patients Linked to More Severe Cardiovascular Problems

June 26, 2014

Cardiovascular risk related to severity of inflammation, but not associated with disease duration